Track Harrow Health Inc. 11.875% Senior Notes due 2027 — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Harrow Health Inc. 11.875% Senior Notes due 2027 HROWM · Stock Open Harrow Health Inc. 11.875% Senior Notes due 2027 in new tab

26.03 USD
Loading chart...

DCF valuation

Model fair value for Harrow Health Inc. 11.875% Senior Notes due 2027 (HROWM)
Result
Sign in to run the valuation for HROWM.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Harrow Health Inc. 11.875% Senior Notes due 2027 Logo Harrow Health Inc. 11.875% Senior Notes due 2027 Analysis (HROWM)

United States Health Care Official Website Stock

Is Harrow Health Inc. 11.875% Senior Notes due 2027 a good investment? Harrow Health Inc. 11.875% Senior Notes due 2027 (HROWM) is currently trading at 26.03 USD.

Investor FAQ

Does Harrow Health Inc. 11.875% Senior Notes due 2027 pay a dividend?

No, it does not currently pay a dividend.

What asset class is Harrow Health Inc. 11.875% Senior Notes due 2027?

Harrow Health Inc. 11.875% Senior Notes due 2027 is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Exchange Ticker
NMS (United States) HROWM
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2025
2.23 USD
July 31, 2025 0.7422
April 30, 2025 0.7422
Jan. 31, 2025 0.7422
▸2024
2.97 USD
Oct. 31, 2024 0.7422
July 31, 2024 0.7422
April 30, 2024 0.7422
Jan. 31, 2024 0.7422
▸2023
2.56 USD
Oct. 31, 2023 0.7422
July 31, 2023 0.7422
April 30, 2023 0.7422
Jan. 31, 2023 0.3381
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion